Advertisement

Heart and Prehypertension

  • Cesare Cuspidi
  • Marijana Tadic
  • Guido Grassi
Chapter
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)

Abstract

Asymptomatic alterations of the cardiovascular system reflect intermediate stages in the disease continuum linking risk factors such as high blood pressure (BP), hypercholesterolemia, diabetes, obesity, and smoking to cardiovascular fatal and nonfatal events. In particular, a variety of manifestations of subclinical target organ damage such as left ventricular hypertrophy (LVH), LV systolic/diastolic dysfunction, abnormalities in small, medium, and large size arteries, and renal impairment have been reported to be associated with systemic hypertension [1, 2].

Keywords

Prehypertension Left ventricular hypertrophy Left ventricular remodeling Left ventricular dysfunction Left atrium Echocardiography 

Notes

Acknowledgement

Disclosure: The authors report no conflicts of interest.

References

  1. 1.
    Martinez MA, Sancho T, Armada E, Rubio JM, Antòn JL, Torre A, Palau J, Seguido P, Gallo J, Saenz I, Polo E, Torres R, Oliver J, Puig JG. Prevalence of left ventricular hypertrophy in patients with mild hypertension in primary care: impact of echocardiography on cardiovascular risk stratification. Am J Hypertens. 2003;16:556–63.CrossRefPubMedGoogle Scholar
  2. 2.
    de Moraes R, Tibirica E. Early functional and structural microvascular changes in hypertension related to aging. Curr Hypertens Rev. 2017;13:24–32.CrossRefPubMedGoogle Scholar
  3. 3.
    Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334–41.CrossRefPubMedGoogle Scholar
  4. 4.
    Cuspidi C, Facchetti R, Bombelli M, Sala C, Tadic M, Grassi G, Mancia G. Prognostic value of left ventricular mass normalized to different body size indexes: findings from the PAMELA population. J Hypertens. 2015;33(5):1082–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Mathiassen OM, Buus NH, Sihm I, Thybo NK, Morn B, Schroeder AP, Thygesen K, Aalkjaer C, Lederballe O, Mulvany MJ, Christensen KL. Small artery structure is an independent predictor of cardiovascular events in essential hypertension. J Hypertens. 2007;25:1021–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, Hua TA, Weber MA, Jamerson K, VALUE Investigators. Prediction of cardiovascular outcomes by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. J Hypertens. 2007;25:1473–9.CrossRefPubMedGoogle Scholar
  7. 7.
    Ruilope LM, Schmieder RE. Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008;21:500–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Weber KT. Fibrosis and hypertensive heart disease. Curr Opin Cardiol. 2000;15:264–72.CrossRefPubMedGoogle Scholar
  9. 9.
    Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–13.CrossRefPubMedGoogle Scholar
  10. 10.
    Huang Y, Wang S, Cai X, Mai W, Hu Y, Tang H, Xu D. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 2013;11:177.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Moreno MU, Eiros R, Gavira JJ, Gallego C, González A, Ravassa S, López B, Beaumont J, San José G, Díez J. The hypertensive myocardium: from microscopic lesions to clinical complications and outcomes. Med Clin North Am. 2017;101:43–52.CrossRefPubMedGoogle Scholar
  12. 12.
    Drukteinis JS, Roman MJ, Fabsitz RR, Lee ET, Best LG, Russell M, Devereux RB. Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study. Circulation. 2007;115:221–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, Vargiu P, Simongini I, Laragh JH. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992;19:1550–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Santos ABS, Gupta DK, Bello NA, Gori M, Claggett B, Fuchs FD, Shah AM, Coresh J, Sharrett AR, Cheng S, Solomon SD. Prehypertension is associated with abnormalities of cardiac structure and function in the atherosclerosis risk in communities study. Am J Hypertens. 2016;29:568–74.CrossRefPubMedGoogle Scholar
  15. 15.
    Li T, Yang J, Guo X, Chen S, Sun Y. Geometrical and functional changes of left heart in adults with prehypertension and hypertension: a cross-sectional study from China. BMC Cardiovasc Disord. 2016;16:114.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Jung JY, Park SK, Oh CM, Kang JG, Choi JM, Ryoo JH, Lee JH. The influence of prehypertension, controlled and uncontrolled hypertension on left ventricular diastolic function and structure in the general Korean population. Hypertens Res. 2017;40:606–12.CrossRefPubMedGoogle Scholar
  17. 17.
    Markus MR, Stritzke J, Lieb W, Mayer B, Luchner A, Döring A, Keil U, Hense HW, Schunkert H. Implications of persistent prehypertension for ageing-related changes in left ventricular geometry and function: the MONICA/KORA Augsburg study. J Hypertens. 2008;26:2040–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Pickering TG, Davidson K, Gerin W, Schwartz JE. Masked hypertension. Hypertension. 2002;40:795–6.CrossRefPubMedGoogle Scholar
  19. 19.
    Shimbo D, Newman JD, Schwartz JE. Masked hypertension and prehypertension: diagnostic overlap and interrelationship with left ventricular mass: the masked hypertension study. Am J Hypertens. 2012;25:664–71.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Norton GR, Maseko M, Libhaber E, Libhaber CD, Majane OH, Dessein P, Sareli P, Woodiwiss AJ. Is prehypertension an independent predictor of target organ changes in young-to-middle-aged persons of African descent ? J Hypertens. 2008;26:2279–87.CrossRefPubMedGoogle Scholar
  21. 21.
    Manios E, Tsivgoulis G, Koroboki E, Stamatelopoulos K, Papamichael C, Toumanidis S, Stamboulis E, Vemmos K, Zakopoulos N. Impact of prehypertension on common carotid artery intima-media thickness and left ventricular mass. Stroke. 2009;40:1515–8.CrossRefPubMedGoogle Scholar
  22. 22.
    Mousa TM, Akinseye OA, Berekashvili K, Akinboboye OO. Correlation of prehypertension with left ventricular mass assessed by cardiac magnetic resonance imaging. Int J Hypertens. 2015;2015, Article ID 742658.CrossRefGoogle Scholar
  23. 23.
    Di Bello V, Talini E, Dell'Omo G, Giannini C, Delle Donne MG, Canale ML, Nardi C, Palagi C, Dini FL, Penno G, Del Prato S, Marzilli M, Pedrinelli R. Early left ventricular mechanics abnormalities in prehypertension: a two-dimensional strain echocardiography study. Am J Hypertens. 2010;23:405–12.CrossRefPubMedGoogle Scholar
  24. 24.
    Tadic M, Majstorovic A, Pencic B, Ivanovic B, Neskovic A, Badano L, Stanisavljevic D, Scepanovic R, Stevanovic P, Celic V. The impact of high-normal blood pressure on left ventricular mechanics: a three-dimensional and speckle tracking echocardiography study. Int J Cardiovasc Imaging. 2014;30:699–711.CrossRefPubMedGoogle Scholar
  25. 25.
    Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Frohlich E, Gonzales A, Diez J. Hypertensive left ventricular hypertrophy risk: beyond adaptive cardiomyocytic hypertrophy. J Hypertens. 2011;29:17–26.CrossRefPubMedGoogle Scholar
  27. 27.
    Chahal NS, Kim TK, Jain P, Chambers JC, Kooner JS, Senior R. New insights into the relationship of left ventricular geometry and left ventricular mass with cardiac function: a population study of hypertensive subjects. Eur Heart J. 2010;31:588–94.CrossRefPubMedGoogle Scholar
  28. 28.
    Zanchetti A, Cuspidi C, Comarella L, Agabiti-Rosei E, Ambrosioni E, Chiarello M, Leonetti G, Mancia G, Pessina AC, Salvetti A, Trimarco B, Volpe M, Grassivaro N, Vargiu G. Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study. J Hypertens. 2007;25:2158–67.CrossRefPubMedGoogle Scholar
  29. 29.
    Urbina EM, Khoury PR, McCoy C, Daniels SR, Kimball TR, Dolan LM. Cardiac and vascular consequences of pre-hypertension in youth. J Clin Hypertens. 2011;13:332–42.CrossRefGoogle Scholar
  30. 30.
    Jang SY, Kim S, Lee CK, Cho EJ, Cho SJ, Lee SC. Prehypertension and left ventricular diastolic dysfunction in middle-aged Koreans. Korean Circ J. 2016;46:536–41.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Douglas P. The left atrium. A biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol. 2003;42:1206–7.CrossRefPubMedGoogle Scholar
  32. 32.
    Tsioufis C, Stougiannos P, Taxiarchou E, Skiadas I, Chatzis D, Thomopoulos C, Lalos S, Stefanadis C, Kallikazaros I. The interplay between hemodynamic load, brain natriuretic peptide and left atrial size in the early stages of essential hypertension. J Hypertens. 2006;24:965–72.CrossRefPubMedGoogle Scholar
  33. 33.
    Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death: the Framingham Heart Study. Circulation. 1995;92:835–41.CrossRefPubMedGoogle Scholar
  34. 34.
    Bombelli M, Facchetti R, Cuspidi C, Villa P, Dozio D, Brambilla G, Grassi G, Mancia G. Prognostic significance of left atrial enlargement in a general population: results of the PAMELA study. Hypertension. 2014;64:1205–11.CrossRefPubMedGoogle Scholar
  35. 35.
    Bombelli M, Cuspidi C, Facchetti R, Sala C, Tadic M, Brambilla G, Re A, Villa P, Grassi G, Mancia G. New-onset left atrial enlargement in a general population. J Hypertens. 2016;34:1838–45.CrossRefPubMedGoogle Scholar
  36. 36.
    Kim SH, Cho GY, Baik I, Lim SY, Choi CU, Lim HE, Kim EJ, Park CG, Park J, Kim J, Shin C. Early abnormalities of cardiovascular structure and function in middle-aged Korean adults with prehypertension: the Korean Genome Epidemiology study. Am J Hypertens. 2011;24:218–24.CrossRefPubMedGoogle Scholar
  37. 37.
    Cipolli JA, Souza FAS, Ferreira-Sae MCS, Magalhaes JAP, Figueiredo ES, Vidotti VG, Matos-Souza JR, Franchini KG, Nadruz W. Sex-specific hemodynamic and non-hemodynamic determinants of aortic root size in hypertensive subjects with left ventricular hypertrophy. Hypertens Res. 2009;32:956–61.CrossRefPubMedGoogle Scholar
  38. 38.
    Covella M, Milan A, Totaro S, Cuspidi C, Re A, Rabbia F, Veglio F. Echocardiographic aortic root dilatation in hypertensive patients: a systematic review and meta-analysis. J Hypertens. 2014;32:1928–35.CrossRefPubMedGoogle Scholar
  39. 39.
    Gardin JM, Arnold AM, Polak J, Jackson S, Smith V, Gottdiener J. Usefulness of aortic root dimension in persons >65 years of age in predicting heart failure, stroke, cardiovascular mortality, all-cause mortality and acute myocardial infarction (from the Cardiovascular Health Study). Am J Cardiol. 2006;97:270–5.CrossRefPubMedGoogle Scholar
  40. 40.
    Cuspidi C, Facchetti R, Bombelli M, Re A, Cairo M, Sala C, Tadic M, Grassi G, Mancia G. Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study. J Hypertens. 2014;32:1879–8.CrossRefPubMedGoogle Scholar
  41. 41.
    Bajpai JK, Sahay AP, Agarwal AK, De AK, Garg B, Goel A. Impact of prehypertension on left ventricular structure, function and geometry. J Clin Diagn Res. 2014;8:BC07–10.PubMedPubMedCentralGoogle Scholar
  42. 42.
    Mancia G, Carugo S, Grassi G, Lanzarotti A, Schiavina R, Cesana GC, Sega R. Prevalence of left ventricular hypertrophy in hypertensive patients without and with blood pressure control: data from the PAMELA population. Hypertension. 2002;39:744–9.CrossRefPubMedGoogle Scholar
  43. 43.
    Abdalla M, Booth JN, Diaz KM, Sims M, Muntner P, Shimbo D. Hypertension and alterations in left ventricular structure and geometry in African Americans: the Jackson Heart Study. J Am Soc Hypertens. 2016;10:550–8.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Nakanishi K, Jin Z, Homma S, Elkind MSV, Rundek T Tugcu A, Sacco RL, Di Tullio MR. Association of blood pressure control level with left ventricular morphology and function and with subclinical cerebrovascular disease. J Am Heart Assoc. 2017;6(8):e006246.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Guo X, Zou L, Zhang X, Li J, Zheng L, Sun Z, Hu J, Wong ND, Sun Y. Prehypertension : a meta-analysis of the epidemiology, risk factors, and predictors of progression. Tex Heart Inst J. 2011;38:643–52.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Cesare Cuspidi
    • 1
    • 2
  • Marijana Tadic
    • 3
  • Guido Grassi
    • 1
    • 4
  1. 1.Department of Medicine and SurgeryUniversity of Milano-BicoccaMilanItaly
  2. 2.Clinical Research UnitIstituto Auxologico ItalianoMedaItaly
  3. 3.Department of CardiologyCharité-University-Medicine Campus Virchow KlinikumBerlinGermany
  4. 4.IRCCS Multimedica, Sesto San GiovanniMilanItaly

Personalised recommendations